Link Pharma Chem Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 376687, "name": "Link Pharma Chem", "stock_name": "Link Pharma Chem", "full_name": "Link Pharma Chem Ltd", "name_url": "stocks-analysis/link-pharma-chem", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "29.49", "chg": 1.49, "chgp": "5.32%", "dir": 1, "prev_price": "28.00", "mcapval": "13.00 Cr", "mcap": "Micro Cap", "scripcode": 524748, "symbol": "", "ind_name": "Commodity Chemicals", "ind_code": 11, "indexname": "India SENSEX", "isin": "INE302F01011", "curr_date": "Apr 17", "curr_time": "", "bse_nse_vol": "389 ", "exc_status": "Active", "traded_date": "Apr 17, 2026", "traded_date_str": "2026 04 17", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/link-pharma-chem-376687-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Link Pharma Chem Ltd Gains 7.42%: Valuation and Technical Shifts Drive Weekly Moves", "link": "https://www.marketsmojo.com/news/stocks-in-action/link-pharma-chem-ltd-gains-742-valuation-and-technical-shifts-drive-weekly-moves-3943168", "imagepath": "", "date": "2026-04-11 17:11:42", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>6 Apr:</strong> Valuation shifts to very attractive amid market challenges</p>\n <p><strong>8 Apr:</strong> Stock surges 8.29% following valuation upgrade</p>\n <p><strong>9 Apr:</strong> Rating upgraded to Sell on improved technicals and valuation</p>\n <p><strong>10 Apr:</strong> Week closes at Rs.28.68, up 7.42% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.26.70</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs...." }, { "title": "Link Pharma Chem Ltd Upgraded to Sell on Improved Technicals and Valuation", "link": "https://www.marketsmojo.com/news/stock-recommendation/link-pharma-chem-ltd-upgraded-to-sell-on-improved-technicals-and-valuation-3938949", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LinkPharmaChemL_mojoScore_3938949.png", "date": "2026-04-09 08:16:04", "description": "Link Pharma Chem Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced improvement across valuation and technical parameters despite persistent fundamental challenges. The micro-cap commodity chemicals company’s recent performance and market signals have prompted a reassessment of its outlook, though caution remains warranted given its weak long-term financial trends." }, { "title": "Link Pharma Chem Ltd Valuation Shifts to Very Attractive Amidst Market Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/link-pharma-chem-ltd-valuation-shifts-to-very-attractive-amidst-market-challenges-3933597", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LinkPharmaChemL_valuationdot_3933597.png", "date": "2026-04-06 08:00:26", "description": "Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating despite ongoing market headwinds and a challenging financial performance. This article analyses the recent changes in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages, and assesses the implications for investors amid a deteriorating stock price and sector dynamics." }, { "title": "Link Pharma Chem Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Underperformance", "link": "https://www.marketsmojo.com/news/stock-recommendation/link-pharma-chem-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-underperformance-3929641", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/LinkPharmaChemL_mojoScore_3929641.png", "date": "2026-04-02 08:20:46", "description": "Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has been downgraded from a Sell to a Strong Sell rating as of 1 April 2026, reflecting deteriorating fundamentals, challenging valuation metrics, and weak technical indicators. Despite some positive quarterly financial results, the company’s long-term performance and financial health continue to raise concerns among investors and analysts alike." }, { "title": "Link Pharma Chem Ltd Upgraded to Sell on Improved Valuation and Financial Trends", "link": "https://www.marketsmojo.com/news/stock-recommendation/link-pharma-chem-ltd-upgraded-to-sell-on-improved-valuation-and-financial-trends-3927025", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LinkPharmaChemL_mojoScore_3927025.png", "date": "2026-03-31 08:19:14", "description": "Link Pharma Chem Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 30 March 2026, driven primarily by a marked improvement in valuation metrics. Despite ongoing challenges in financial trends and quality parameters, the stock’s very attractive valuation has prompted a reassessment by analysts, signalling a cautious but more optimistic stance amid persistent operational headwinds." }, { "title": "Link Pharma Chem Ltd’s Volatile Week: -0.84% Price Change Amid Mixed Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/link-pharma-chem-ltds-volatile-week--084-price-change-amid-mixed-signals-3922899", "imagepath": "", "date": "2026-03-29 11:01:00", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>16 Mar:</strong> Stock hits 52-week low amid downtrend (Rs.23.40)</p>\n <p><strong>17 Mar:</strong> Further 52-week low recorded (Rs.21.86)</p>\n <p><strong>18 Mar:</strong> MarketsMOJO upgrades rating to Sell; stock rallies 12.03% (Rs.24.49)</p>\n <p><strong>19 Mar:</strong> Price retreats amid Sensex plunge (Rs.23.50)</p>\n <p><strong>20 Mar:</strong> Stock rebounds 5.79% to close week at Rs.24.86</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.25.07</div></div>\n ..." }, { "title": "Link Pharma Chem Ltd Falls 8.93%: Downgrade and Valuation Shift Shape Volatile Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/link-pharma-chem-ltd-falls-893-downgrade-and-valuation-shift-shape-volatile-week-3922153", "imagepath": "", "date": "2026-03-28 16:04:29", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 23:</strong> Stock closes at Rs.24.70, down 0.64% amid Sensex plunge</p>\n <p><strong>Mar 24:</strong> Downgrade to Strong Sell and valuation shift announced</p>\n <p><strong>Mar 25:</strong> Sharp 3.29% decline on heavy volume</p>\n <p><strong>Mar 27:</strong> Week ends with 6.17% drop to Rs.22.64</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.24.86</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.22.64</div><div class=\"sta..." }, { "title": "Link Pharma Chem Ltd Downgraded to Strong Sell Amid Mixed Financial Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/link-pharma-chem-ltd-downgraded-to-strong-sell-amid-mixed-financial-signals-3909392", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LinkPharmaChemL_mojoScore_3909392.png", "date": "2026-03-24 08:28:41", "description": "Link Pharma Chem Ltd has seen its investment rating upgraded from Sell to Strong Sell as of 23 March 2026, driven primarily by an improvement in valuation metrics despite ongoing challenges in financial trends and quality parameters. The micro-cap commodity chemicals company’s latest assessment by MarketsMOJO reflects a nuanced view balancing attractive valuation against weak profitability and technical underperformance." }, { "title": "Link Pharma Chem Ltd Valuation Shifts to Attractive Amidst Challenging Market Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/link-pharma-chem-ltd-valuation-shifts-to-attractive-amidst-challenging-market-returns-3908995", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LinkPharmaChemL_valuationdot_3908995.png", "date": "2026-03-24 08:00:50", "description": "Link Pharma Chem Ltd has witnessed a notable change in its valuation parameters, moving from a very attractive to an attractive price level, despite ongoing challenges in profitability and returns. This shift in price-to-earnings and price-to-book value ratios, when analysed against historical trends and peer comparisons, offers investors a nuanced perspective on the stock’s current market positioning within the commodity chemicals sector." } ], "total": 106, "sid": "376687", "stock_news_url": "https://www.marketsmojo.com/news/link-pharma-chem-376687" }, "announcements": [ { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "08-Apr-2026", "details": "We are enclosed herewith the confirmation certificate under Regulation 74(5) of SEBI(DP) Regulation 2018 for quarter ended March 31 2026 received from MUFG Intime India Private Limited (Formerly known as Link Intime India Private Limited) RTA of the Company.", "source": "BSE" }, { "caption": "Closure of Trading Window", "datetime": "26-Mar-2026", "details": "Intimation for Trading window closure.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "16-Feb-2026", "details": "Newspaper advertisement of unaudited financial results for the quarter and Nine months ended December 31 2025", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

6 Apr: Valuation shifts to very attractive amid market challenges

8 Apr: Stock surges 8.29% following valuation upgrade

9 Apr: Rating upgraded to Sell on improved technicals and valuation

10 Apr: Week closes at Rs.28.68, up 7.42% for the week

Read full news article

Link Pharma Chem Ltd Upgraded to Sell on Improved Technicals and Valuation

2026-04-09 08:16:04

Link Pharma Chem Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced improvement across valuation and technical parameters despite persistent fundamental challenges. The micro-cap commodity chemicals company’s recent performance and market signals have prompted a reassessment of its outlook, though caution remains warranted given its weak long-term financial trends.

Read full news article

Link Pharma Chem Ltd Valuation Shifts to Very Attractive Amidst Market Challenges

2026-04-06 08:00:26

Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating despite ongoing market headwinds and a challenging financial performance. This article analyses the recent changes in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages, and assesses the implications for investors amid a deteriorating stock price and sector dynamics.

Read full news article

Link Pharma Chem Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Underperformance

2026-04-02 08:20:46

Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has been downgraded from a Sell to a Strong Sell rating as of 1 April 2026, reflecting deteriorating fundamentals, challenging valuation metrics, and weak technical indicators. Despite some positive quarterly financial results, the company’s long-term performance and financial health continue to raise concerns among investors and analysts alike.

Read full news article

Link Pharma Chem Ltd Upgraded to Sell on Improved Valuation and Financial Trends

2026-03-31 08:19:14

Link Pharma Chem Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 30 March 2026, driven primarily by a marked improvement in valuation metrics. Despite ongoing challenges in financial trends and quality parameters, the stock’s very attractive valuation has prompted a reassessment by analysts, signalling a cautious but more optimistic stance amid persistent operational headwinds.

Read full news article

Link Pharma Chem Ltd’s Volatile Week: -0.84% Price Change Amid Mixed Signals

2026-03-29 11:01:00

Key Events This Week

16 Mar: Stock hits 52-week low amid downtrend (Rs.23.40)

17 Mar: Further 52-week low recorded (Rs.21.86)

18 Mar: MarketsMOJO upgrades rating to Sell; stock rallies 12.03% (Rs.24.49)

19 Mar: Price retreats amid Sensex plunge (Rs.23.50)

20 Mar: Stock rebounds 5.79% to close week at Rs.24.86

Week Open

Rs.25.07

...

Read full news article

Link Pharma Chem Ltd Falls 8.93%: Downgrade and Valuation Shift Shape Volatile Week

2026-03-28 16:04:29

Key Events This Week

Mar 23: Stock closes at Rs.24.70, down 0.64% amid Sensex plunge

Mar 24: Downgrade to Strong Sell and valuation shift announced

Mar 25: Sharp 3.29% decline on heavy volume

Mar 27: Week ends with 6.17% drop to Rs.22.64

Read full news article

Link Pharma Chem Ltd Downgraded to Strong Sell Amid Mixed Financial Signals

2026-03-24 08:28:41

Link Pharma Chem Ltd has seen its investment rating upgraded from Sell to Strong Sell as of 23 March 2026, driven primarily by an improvement in valuation metrics despite ongoing challenges in financial trends and quality parameters. The micro-cap commodity chemicals company’s latest assessment by MarketsMOJO reflects a nuanced view balancing attractive valuation against weak profitability and technical underperformance.

Read full news article

Link Pharma Chem Ltd Valuation Shifts to Attractive Amidst Challenging Market Returns

2026-03-24 08:00:50

Link Pharma Chem Ltd has witnessed a notable change in its valuation parameters, moving from a very attractive to an attractive price level, despite ongoing challenges in profitability and returns. This shift in price-to-earnings and price-to-book value ratios, when analysed against historical trends and peer comparisons, offers investors a nuanced perspective on the stock’s current market positioning within the commodity chemicals sector.

Read full news article

View All News